^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    eltanexor (KPT-8602)

    i
    Company:
    Antengene, Karyopharm, Ono Pharma
    Drug class:
    XPO1 inhibitor, Nuclear export inhibitor
    Related drugs:
    Apply
    Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications (KCP-8602-801) (NCT02649790)
    Phase 1/2
    Karyopharm Therapeutics Inc
    Active, not recruiting
    Last update posted :
    05/24/2024
    Initiation :
    01/01/2016
    Primary completion :
    08/31/2024
    Completion :
    12/31/2024
    KRAS
    |
    KRAS wild-type • RAS wild-type
    |
    abiraterone acetate • dexamethasone • Inqovi (decitabine/cedazuridine) • eltanexor (KPT-8602)